• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种适用于血浆检测的、用于外源性(组织型)纤溶酶原激活剂的简单、灵敏的分光光度测定法。

A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma.

作者信息

Verheijen J H, Mullaart E, Chang G T, Kluft C, Wijngaards G

出版信息

Thromb Haemost. 1982 Dec 27;48(3):266-9.

PMID:6891841
Abstract

An indirect spectrophotometric assay for extrinsic plasminogen activator has been devised, which is based on the parabolic assay of Drapier et al. (5). The system contains activator, plasminogen, the synthetic plasmin substrate H-D-Val-Leu-Lys-pNA (S-2251, Kabi) and a mixture of soluble fibrinogen fragments prepared by treatment of fibrinogen with cyanogen bromide. The addition of these fibrinogen fragments considerably enhances the sensitivity and specificity of the method owing to specific stimulation of the plasminogen activation by extrinsic plasminogen activator. The assay conditions were optimized and the application for extrinsic plasminogen activator measurements in plasma euglobulin fractions is demonstrated.

摘要

已设计出一种用于外源性纤溶酶原激活剂的间接分光光度测定法,该方法基于Drapier等人(5)的抛物线测定法。该系统包含激活剂、纤溶酶原、合成纤溶酶底物H-D-缬氨酸-亮氨酸-赖氨酸-对硝基苯胺(S-2251,卡比)以及通过用溴化氰处理纤维蛋白原制备的可溶性纤维蛋白原片段混合物。由于外源性纤溶酶原激活剂对纤溶酶原激活的特异性刺激,这些纤维蛋白原片段的加入大大提高了该方法的灵敏度和特异性。对测定条件进行了优化,并展示了该方法在血浆优球蛋白组分中外源性纤溶酶原激活剂测量中的应用。

相似文献

1
A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma.一种适用于血浆检测的、用于外源性(组织型)纤溶酶原激活剂的简单、灵敏的分光光度测定法。
Thromb Haemost. 1982 Dec 27;48(3):266-9.
2
A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate.一种使用缓慢水解的纤溶酶底物来测定纤溶酶原激活剂催化效率的分光光度测定法。
Anal Biochem. 1995 Apr 10;226(2):225-31. doi: 10.1006/abio.1995.1218.
3
Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.适用于溶栓实验研究的大鼠血浆中功能性纤溶酶原测定法。
Thromb Haemost. 2000 Aug;84(2):299-306.
4
Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.荧光素标记的纤维蛋白原和纤维蛋白有助于在充分混合的条件下进行大分子组装以及对皮摩尔水平的纤溶酶原激活剂进行动态检测。
Thromb Haemost. 1995 Aug;74(2):711-7.
5
Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay.
J Lab Clin Med. 1983 Feb;101(2):285-94.
6
Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay.
Thromb Haemost. 1986 Apr 30;55(2):189-93.
7
Current status of activity assays for tissue plasminogen activator.组织型纤溶酶原激活物活性测定的现状
Ann N Y Acad Sci. 1984;434:536-40. doi: 10.1111/j.1749-6632.1984.tb29889.x.
8
Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay.
J Lab Clin Med. 1983 Feb;101(2):274-84.
9
The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.含有人纤溶酶原kringle结构域的嵌合型尿激酶型纤溶酶原激活剂基因的构建与表达
Arch Biochem Biophys. 1993 Jun;303(2):222-30. doi: 10.1006/abbi.1993.1276.
10
[Determination of the enzyme activity of the fibrinolytic system using fibrinogen conjugated with peroxidase].[使用与过氧化物酶偶联的纤维蛋白原测定纤维蛋白溶解系统的酶活性]
Lab Delo. 1991(11):27-31.

引用本文的文献

1
A novel ex vivo approach for measuring plasminogen activation upon established plasma clots.一种用于测量已形成血浆凝块上纤溶酶原激活的新型体外方法。
Res Pract Thromb Haemost. 2022 Jul 21;6(5). doi: 10.1002/rth2.12771. eCollection 2022 Jul.
2
Measuring fibrinolysis: from research to routine diagnostic assays.测量纤维蛋白溶解:从研究到常规诊断检测。
J Thromb Haemost. 2018 Apr;16(4):652-662. doi: 10.1111/jth.13957. Epub 2018 Feb 17.
3
Pharmacodynamic Effects of Sulodexide on Profibrinolytic and Haemorrheological Patterns.舒洛地昔对纤溶和血液流变学模式的药效学作用。
Clin Drug Investig. 1995 Sep;10(3):165-71. doi: 10.2165/00044011-199510030-00005.
4
High-level expression of a novel recombinant human plasminogen activator (rhPA) in the milk of transgenic rabbits and its thrombolytic bioactivity in vitro.新型重组人纤溶酶原激活剂(rhPA)在转基因兔乳汁中的高效表达及其体外溶栓生物活性
Mol Biol Rep. 2016 Aug;43(8):775-83. doi: 10.1007/s11033-016-4020-0. Epub 2016 May 26.
5
Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury.机械通气相关性肺损伤期间支气管肺泡的凝血激活与纤溶抑制
Crit Care Res Pract. 2012;2012:961784. doi: 10.1155/2012/961784. Epub 2012 Apr 17.
6
Structure, stability, and interaction of fibrin αC-domain polymers.纤维蛋白 αC 结构域聚合物的结构、稳定性和相互作用。
Biochemistry. 2011 Sep 20;50(37):8028-37. doi: 10.1021/bi2008189. Epub 2011 Aug 24.
7
Blood transfusion during cardiac surgery is associated with inflammation and coagulation in the lung: a case control study.心脏手术期间输血与肺部炎症和凝血有关:一项病例对照研究。
Crit Care. 2011;15(1):R59. doi: 10.1186/cc10032. Epub 2011 Feb 11.
8
Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial.改变脂肪和碳水化合物的数量和类型对胰岛素敏感性和心血管风险的影响:RISCK(雷丁、帝国理工学院、萨里、剑桥和国王学院)试验。
Am J Clin Nutr. 2010 Oct;92(4):748-58. doi: 10.3945/ajcn.2009.29096. Epub 2010 Aug 25.
9
Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study.莱顿因子 V 突变对肺炎球菌性肺炎结局的影响:一项对照实验室研究。
Crit Care. 2010;14(4):R145. doi: 10.1186/cc9213. Epub 2010 Aug 3.
10
Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study.活化蛋白 C 可改善凝血功能障碍,但不能影响致死性 H1N1 流感的结局:一项对照实验室研究。
Crit Care. 2010;14(2):R65. doi: 10.1186/cc8964. Epub 2010 Apr 14.